Pharsight

ONCOPEPTIDES AB PATENTS FACING OPPOSITIONS

Top patents of ONCOPEPTIDES AB facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3383385B2 06 Sep, 2023 Melflufen Dosage Regimens For Cancer Dec, 2036 2